The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Monoclonal Antibody Therapeutics Market Research Report 2024

Global Monoclonal Antibody Therapeutics Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1905235

No of Pages : 84

Ask Your Query

Synopsis

The global Monoclonal Antibody Therapeutics market was valued at US$ 114190 million in 2023 and is anticipated to reach US$ 190750 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.

North American market for Monoclonal Antibody Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Monoclonal Antibody Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Monoclonal Antibody Therapeutics in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Monoclonal Antibody Therapeutics include Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie and Amgen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody Therapeutics.

Report Scope

The Monoclonal Antibody Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibody Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibody Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Bayer
  • F. Hoffmann-La Roche
  • Pfizer
  • Sanofi
  • GlaxoSmithKline
  • Merck
  • Novartis
  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Bristol-Myers Squibb Company
  • Biogen

Segment by Type

  • Humanized Antibody
  • Human Mouse Chimeric Antibody

Segment by Application

  • Cancer
  • Autoimmune Diseases
  • Infection
  • Hematological Diseases
  • Ophthalmological Diseases
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibody Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Humanized Antibody
1.2.3 Human Mouse Chimeric Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2019-2030)
2.2 Monoclonal Antibody Therapeutics Growth Trends by Region
2.2.1 Global Monoclonal Antibody Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Monoclonal Antibody Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Monoclonal Antibody Therapeutics Market Dynamics
2.3.1 Monoclonal Antibody Therapeutics Industry Trends
2.3.2 Monoclonal Antibody Therapeutics Market Drivers
2.3.3 Monoclonal Antibody Therapeutics Market Challenges
2.3.4 Monoclonal Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue
3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2023
3.5 Monoclonal Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Therapeutics Breakdown Data by Type
4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2025-2030)
5 Monoclonal Antibody Therapeutics Breakdown Data by Application
5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Monoclonal Antibody Therapeutics Market Size (2019-2030)
6.2 North America Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Monoclonal Antibody Therapeutics Market Size by Country (2019-2024)
6.4 North America Monoclonal Antibody Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Market Size (2019-2030)
7.2 Europe Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Country (2019-2024)
7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Therapeutics Market Size (2019-2030)
9.2 Latin America Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.9.5 Amgen Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.10.5 Johnson & Johnson Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Detail
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Biogen
11.12.1 Biogen Company Detail
11.12.2 Biogen Business Overview
11.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
11.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2019-2024)
11.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock